Stress, acute hyperglycemia, and hyperlipidemia: Role of the autonomic nervous system and cytokines

Trends in Endocrinology and Metabolism

Volumn 8, Issue 5, 1997, Pages 192-197

  Nonogaki, Katsunori ^a   Iguchi, Akihisa ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC ACTIVITY; ARTERIOSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPOLYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVIEW; STRESS;

EID: 0030743860     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00038-6     Document Type: Article

References (46)

1. Aloe L, Alleva E, Bohm A, Levi-Montalcini R: 1986. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci USA 83:6184-6187.
2. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P: 1994. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA 91:10,440-10,444.
3. Blumberg D, Hochwald S, Brennan MF, Burt M: 1995. Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes. Metabolism 44:145-146.
4. Boden G: 1996. Fatty acids and insulin resistance. Diabetes Care 19:394-395.
5. Brown MR: 1990. Role of brain peptides in the regulation of metabolism. In Rifkin H, Porte D, eds. Diabetes Mellitus. New York, Elsevier, pp 170-174.
6. De Simoni MG, Sironi M, De Luigi A, et al.: 1990. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med 171:1773-1778.
7. Gotoh M, Iguchi A, Yatomi A, et al.: 1989. Vagally mediated insulin secretion by stimulation of brain cholinergic neurons with neostigmine in bilateral adneralectomized rats. Brain Res 493:97-102.
8. Greenberg AS, Nordan RP, Mcintosh J, Calvo JC, Scow RO, Jablons D: 1992. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52:4113-4116.
9. Grunfeld C, Soued M, Adi S, et al.: 1991. Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not interferon-α. Cancer Res 51:2803-2807.
10. Hardardottir I, Grunfeld C, Feingold KR: 1994. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-215.
11. Hirano T, Matsuda T, Nakajima K: 1994. Signal transduction through gp130 that is shared among the receptors for the interleukin-6 related to cytokine subfamily. Stem Cells 12: 262-277.
12. Honmura A, Yanase M, Saito H, Iguchi A: 1992. Effect of intrahypothalamic injection of neostigmine on the secretion of epinephrine and norepinephrine and on plasma glucose level. Endocrinology 130:2997-3002.
13. Iguchi A, Gotoh M, Matsunaga H, et al.: 1988. Relative contributions of the nervous system and hormones to the CNS-mediated hyperglycemia. Am J Physiol 255:E920-E927.
14. Iguchi A, Kunoh Y, Miura H, et al.: 1989a. Central nervous system control of glycogenolysis and gluconeogenesis in fed and fasted rat liver. Metabolism 38:1216-1221.
15. Iguchi A, Gotoh M, Matsunaga H, et al.: 1989b. Central nervous system-mediated glucagon secretion is enhanced by α2-adrenoceptor activation. Endocrinology 125:1581-1586.
16. Iguchi A, Uemura K, Miura H, et al.: 1992. Mechanism of intrahippocampal neostigmine-induced hyperglycemia in fed rats. Neuroendocrinology 55:44-50.
17. Ishiguro T, Iguchi A, Kunoh Y, et al.: 1991. The relative contribution of nervous system and hormones to hyperglycemia induced by thyrotropin-releasing hormone in fed rats. Neuroendocrinology 54:1-6.
18. Kunoh Y, Iguchi A, Uemura K, et al.: 1992. Effects of adrenergic blockers on central nervous system-mediated hyperglycemia in fed rats. Metabolism 41:471-475.
19. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger WE: 1995. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268:R896-R901.
20. Linden W, Stossel C, Maurice J: 1996. Psychological interventions for patients with coronary artery disease. Arch Intern Med 156: 745-752.
21. Lonnqvist F, Wennlund A, Wahrenberg H, Arner P: 1992. Effects of mental stress on lipolysis in humans. Metabolism 41:622-630.
22. Matsunaga H, Iguchi A, Yatomi A, et al.: 1989. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats. Endocrinology 124:1259-1264.
23. Missale C, Broni F, Sigala S, et al.: 1996. Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci USA 93: 4240-4245.
24. Muldoon MF, Bachen EA, Manuck SB, et al.: 1992. Acute cholesterol responses to mental stress and change in posture. Arch Intern Med 152:775-780.
25. Nonogaki K, Iguchi A: 1997. Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci 60:797-807.
26. Nonogaki K, Iguchi A, Sakamoto N: 1994a. Effects of adrenoceptor antagonists on hyperglycemia and hyperthermia induced by PGF2α in rats. Eur J Pharmacol 262:177-180.
27. Nonogaki K, Moser AH, Feingold KR, Grunfeld C: 1994b. α-Adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats. Endocrinolgy 135:2644-2650.
28. Nonogaki K, Fuller GM, Fuentes NL, et al.: 1995a. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136: 2143-2149.
29. Nonogaki K, Pan X-M, Mose AH, Staprans I, Feingold KR, Grunfeld C: 1995b. Keratinocyte growth factor increases fatty acid mobilization and hepatic triglyceride secretion in rats. Endocrinology 136:4278-4284.
30. Nonogaki K, Moser AH, Pan X-M, Staprans I, Grunfeld C, Feingold KR: 1995c. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. J Lipid Res 36:1987-1995.
31. Nonogaki K, Moser AH, Shigenaga J, et al.: 1996a. β-Nerve growth factor as a mediator of the acute phase response in vivo. Biochem Biophys Res Commun 219:956-961.
32. Nonogaki K, Pan X-M, Moser AH, et al.: 1996b. LIF and CNTF, which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats. Am J Physiol 271:E521-E528.
33. Patterson SM, Gottdiener JS, Hecht G, Vargot S, Krantz DS: 1993. Effects of acute mental stress on serum lipids: mediating effects of plasma volume. Psychosom Med 55:525-532.
34. Raikkonen K, Keltikangas-Jarvinen L, Adlercreutz H, Hautanen A: 1996. Psychological stress and the insulin resistance syndrome. Metabolism 45:1533-1538.
35. Shimazu T: 1981. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20:343-356.
36. Shintani F, Nakai T, Kanba S, et al.: 1995. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticoid hormone and in release of hypothalamic monoamines in the rats. J Neurosci 15:1961-1970.
37. Soszynski D, Kozak W, Conn CA, Rudolph K, Kluger MJ: 1996. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology 63:459-467.
38. Stein TP, Schluter MD: 1994. Excretion of IL-6 by astronauts during spaceflight. Am J Physiol 266:E448-E452.
39. Surwit RS, Schneider MS, Feinglos MN: 1992. Stress and diabetes mellitus. Diabetes Care 15:1413-1422.
40. Taggart P, Carruthers M: 1971. Endogenous hyperlipidemia induced by emotional stress of racing driving. Lancet 1:363-366.
41. Thernlund GM, Ludvigsson J, Dahlquist G, et al.: 1995. Psychological stress and the onset of IDDM in children. Diabetes Care 18:1323-1329.
42. Uemura K, Iguchi A, Yatomi A, et al.: 1989. Involvement of the hippocampus in central nervous system-mediated glucoregulation in rats. Endocrinology 124:2449-2455.
43. Van Der Does FE, Grootenhuis PA, De Neeling JD, et al.: 1996. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 19:204-210.
44. Weinberger MH: 1985. Antihypertensive therapy and lipids: evidence mechanisms and implications. Arch Intern Med 145:1102-1105.
45. Yatomi A, Iguchi A, Yanagisawa S, Matsunaga H, Niki I, Sakamoto N: 1987. Prostaglandins affect the central nervous system to produce hyperglycemia in rats. Endocrinology 121: 36-41.
46. Zhou D, Kusnecov AW, Shurin MR, Depaoli M, Rabin BS: 1993. Exposure to physical and psychological Stressors elevates plasma interleukin-6 activity in rats. Endocrinology 133: 2523-2530. TEM